The effects of irreversible electroporation on the stomach wall after ablating hepatic tissues
- 64 Downloads
This study aimed to evaluate the effect of irreversible electroporation (IRE) on the stomach wall after IRE was applied on liver tissues adjacent to the anterior wall of the stomach. IRE ablation was performed in eight Tibet mini-pigs with three lesions per pig. The IRE electrodes were inserted into the liver tissues situated close to the anterior wall of the stomach. As for the control group, the IRE electrodes were also inserted into the liver tissues for three lesions in four Tibet mini-pigs but did not turn on the current. Serum aminotransferase and WBC levels clearly increased in all the IRE ablated animals by Day 1 and decreased gradually thereafter. The gross postmortem examination at 7 days post-IRE revealed a whitish lesion with sharp demarcation on the serosal surface of the stomach, but we could not find any signs of ablation or just find a small, slightly reddish lesion at the Day-28 examination. On the Day-7 histopathological examination, inflammation and fibrosis were observed in the serosal layer of the stomach in each animal and mild inflammation of the myofibers was found in only two pigs. All the stomach layers returned to normalcy by 28 days post-IRE. Thus, IRE ablation of hepatic tissues situated close to the stomach wall cannot lead to stomach perforation. IRE is therefore a safe procedure for ablating hepatic tumors that are adjacent to the stomach.
KeywordsIrreversible electroporation Liver Stomach
We thank Elixigen Corporation (Huntington Beach, California, USA) for helping in proofreading and editing the English of final manuscript.
Compliance with ethical standards
The authors declare that they have no competing interests.
- W. Cheung, H. Kavnoudias, S. Roberts, B. Szkandera, W. Kemp, K.R. Thomson, Irreversible electroporation for unresectable hepatocellular carcinoma: Initial experience and review of safety and outcomes. Technol Cancer Res Treat 12, 233–241 (2013). https://doi.org/10.7785/tcrt.2012.500317 Epub 2013 Jan 25CrossRefGoogle Scholar
- W. van den Bos, D.M. de Bruin, B.G. Muller, I.M. Varkarakis, A.A. Karagiannis, P.J. Zondervan, et al., The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: A multicentre prospective human in vivo pilot study protocol. BMJ Open 4, e006382 (2014). https://doi.org/10.1136/bmjopen-2014- CrossRefGoogle Scholar
- A. Eller, A. Schmid, J. Schmidt, M. May, M. Brand, M. Saake, et al., Local control of perivascular malignant liver lesions using percutaneous irreversible electroporation: Initial experiences. Cardiovasc. Intervent. Radiol. 38, 152–159 (2015). https://doi.org/10.1007/s00270-014-0898-x Epub 2014 May 6CrossRefGoogle Scholar
- J. Fanta, P. Horak, J. Marvan, M. Masek, M. Kaspar, N. Pauk, et al., The NanoKnife and two successful cases of intracavitary irreversible electroporation of main bronchus tumours. Rozhl. Chir. 91, 625–630 (2012)Google Scholar
- Hosein PJ, Echenique A, Loaiza-Bonilla A, Froud T, Barbery K, Rocha Lima CM, et al. Percutaneous irreversible electroporation for the treatment of colorectal cancer liver metastases with a proposal for a new response evaluation system. J Vasc Interv Radiol 2014;25:1233–9.e2. https://doi.org/10.1016/j.jvir.2014.04.007. Epub May 24
- T.P. Kingham, A.M. Karkar, M.I. D'Angelica, P.J. Allen, R.P. Dematteo, G.I. Getrajdman, et al., Ablation of perivascular hepatic malignant tumors with irreversible electroporation. J. Am. Coll. Surg. 215, 379–387 (2012). https://doi.org/10.1016/j.jamcollsurg.2012.04.029 Epub Jun 16CrossRefGoogle Scholar
- Y.J. Lee, D.S. Lu, F. Osuagwu, C. Lassman, Irreversible electroporation in porcine liver: Short- and long-term effect on the hepatic veins and adjacent tissue by CT with pathological correlation. Investig. Radiol. 47, 671–675 (2012). https://doi.org/10.1097/RLI.0b013e318274b0df CrossRefGoogle Scholar
- R.C. Martin 2nd, D. Kwon, S. Chalikonda, M. Sellers, E. Kotz, C. Scoggins, et al., Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation: Safety and efficacy. Ann. Surg. 262, 486–494; discussion 92-4 (2015). https://doi.org/10.1097/SLA.0000000000001441 CrossRefGoogle Scholar
- Scheffer H, Nielsen K, van Tilborg A, Vieveen JM, van den Tol MP, Meijerink MR. [Irreversible electroporation: a new form of image-guided tumour ablation]. Ned. Tijdschr. Geneeskd. 2014;158Google Scholar
- H. Schoellnast, S. Monette, P.C. Ezell, A. Deodhar, M. Maybody, J.P. Erinjeri, et al., Acute and subacute effects of irreversible electroporation on nerves: Experimental study in a pig model. Radiology 260, 421–427 (2011a). https://doi.org/10.1148/radiol.11103505 Epub 2011 Jun 3CrossRefGoogle Scholar
- H. Schoellnast, S. Monette, P.C. Ezell, G. Single, M. Maybody, M.R. Weiser, et al., Irreversible electroporation adjacent to the rectum: Evaluation of pathological effects in a pig model. Cardiovasc. Intervent. Radiol. 36, 213–220 (2013). https://doi.org/10.1007/s00270-012-0393-1 Epub 2012 May 5CrossRefGoogle Scholar